Large-scale screening for somatic mutations in lung cancer von Rosell, Rafael, Karachaliou, Niki

Volltext

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC) von Moya-Horno, Irene, Viteri, Santiago, Karachaliou, Niki, Rosell, Rafael

Volltext

Genetics and biomarkers in personalisation of lung cancer treatment von Rosell, Rafael, Dr, Bivona, Trever G, MD, Karachaliou, Niki, MD

Volltext

AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy von Bertran-Alamillo, Jordi, Cattan, Valérie, Schoumacher, Marie, Codony-Servat, Jordi, Giménez-Capitán, Ana, Cantero, Frédérique, Burbridge, Mike, Rodríguez, Sonia, Teixidó, Cristina, Roman, Ruth, Castellví, Josep, García-Román, Silvia, Codony-Servat, Carles, Viteri, Santiago, Cardona, Andrés-Felipe, Karachaliou, Niki, Rosell, Rafael, Molina-Vila, Miguel-Angel

Volltext

Clinical assessment of immune-related adverse events von Sosa, Aaron, Lopez Cadena, Esther, Simon Olive, Cristina, Karachaliou, Niki, Rosell, Rafael

Volltext

Tumor immune microenvironment characterization and response to anti-PD-1 therapy von Santarpia, Mariacarmela, Karachaliou, Niki

Volltext

Implications of Blood-Based T790M Genotyping and Beyond in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer von Rosell, Rafael, Karachaliou, Niki

Volltext

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients von Karachaliou, Niki, Gonzalez-Cao, Maria, Crespo, Guillermo, Drozdowskyj, Ana, Aldeguer, Erika, Gimenez-Capitan, Ana, Teixido, Cristina, Molina-Vila, Miguel Angel, Viteri, Santiago, De Los Llanos Gil, Maria, Algarra, Salvador Martin, Perez-Ruiz, Elisabeth, Marquez-Rodas, Ivan, Rodriguez-Abreu, Delvys, Blanco, Remedios, Puertolas, Teresa, Royo, Maria Angeles, Rosell, Rafael

Volltext

Human endogenous retroviruses and cancer von Gonzalez-Cao, María, Iduma, Paola, Karachaliou, Niki, Santarpia, Mariacarmela, Blanco, Julià, Rosell, Rafael

Volltext

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer? von Lazzari, Chiara, Karachaliou, Niki, Bulotta, Alessandra, Viganó, Mariagrazia, Mirabile, Aurora, Brioschi, Elena, Santarpia, Mariacarmela, Gianni, Luca, Rosell, Rafael, Gregorc, Vanesa

Volltext

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer von Bell, Erica Hlavin, Chakraborty, Arup R, Mo, Xiaokui, Liu, Ziyan, Shilo, Konstantin, Kirste, Simon, Stegmaier, Petra, McNulty, Maureen, Karachaliou, Niki, Rosell, Rafael, Bepler, Gerold, Carbone, David P, Chakravarti, Arnab

Volltext

BRAFV600E and BRAF-inactivating mutations in NSCLC von Rosell, Rafael, Karachaliou, Niki

Volltext

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer von Jacobsen, Kirstine, Bertran-Alamillo, Jordi, Molina, Miguel Angel, Teixidó, Cristina, Karachaliou, Niki, Pedersen, Martin Haar, Castellví, Josep, Garzón, Mónica, Codony-Servat, Carles, Codony-Servat, Jordi, Giménez-Capitán, Ana, Drozdowskyj, Ana, Viteri, Santiago, Larsen, Martin R., Lassen, Ulrik, Felip, Enriqueta, Bivona, Trever G., Ditzel, Henrik J., Rosell, Rafael

Volltext

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC von Chaib, Imane, Karachaliou, Niki, Pilotto, Sara, Codony Servat, Jordi, Cai, Xueting, Li, Xuefei, Drozdowskyj, Ana, Servat, Carles Codony, Yang, Jie, Hu, Chunping, Cardona, Andres Felipe, Vivanco, Guillermo Lopez, Vergnenegre, Alain, Sanchez, Jose Miguel, Provencio, Mariano, de Marinis, Filipo, Passaro, Antonio, Carcereny, Enric, Reguart, Noemi, Campelo, Charo Garcia, Teixido, Christina, Sperduti, Isabella, Rodriguez, Sonia, Lazzari, Chiara, Verlicchi, Alberto, de Aguirre, Itziar, Queralt, Cristina, Wei, Jia, Estrada, Roger, Puig de la Bellacasa, Raimon, Ramirez, Jose Luis, Jacobson, Kirstine, Ditzel, Henrik J, Santarpia, Mariacarmela, Viteri, Santiago, Molina, Migual Angel, Zhou, Caicun, Cao, Peng, Ma, Patrick C, Bivona, Trever G, Rosell, Rafael

Volltext

Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape von Simard, Manon A, Cabrera-Galvez, Carlos, Viteri, Santiago, Geist, Felix, Reischmann, Nadine, Zühlsdorf, Michael, Karachaliou, Niki

Volltext

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis von Duruisseaux, Michäel, Martínez-Cardús, Anna, Calleja-Cervantes, Maria E, Moran, Sebastian, Castro de Moura, Manuel, Davalos, Veronica, Piñeyro, David, Sanchez-Cespedes, Montse, Girard, Nicolas, Brevet, Marie, Giroux-Leprieur, Etienne, Dumenil, Coraline, Pradotto, Monica, Bironzo, Paolo, Capelletto, Enrica, Novello, Silvia, Cortot, Alexis, Copin, Marie-Christine, Karachaliou, Niki, Gonzalez-Cao, Maria, Peralta, Sergio, Montuenga, Luis M, Gil-Bazo, Ignacio, Baraibar, Iosune, Lozano, Maria D, Varela, Mar, Ruffinelli, Jose C, Palmero, Ramon, Nadal, Ernest, Moran, Teresa, Perez, Lidia, Ramos, Immaculada, Xiao, Qingyang, Fernandez, Agustin F, Fraga, Mario F, Gut, Marta, Gut, Ivo, Teixidó, Cristina, Vilariño, Noelia, Prat, Aleix, Reguart, Noemi, Benito, Amparo, Garrido, Pilar, Barragan, Isabel, Emile, Jean-François, Rosell, Rafael, Brambilla, Elisabeth, Esteller, Manel

Volltext

Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies von Santarpia, Mariacarmela, Aguilar, Andrés, Chaib, Imane, Cardona, Andrés Felipe, Fancelli, Sara, Laguia, Fernando, Bracht, Jillian Wilhelmina Paulina, Cao, Peng, Molina-Vila, Miguel Angel, Karachaliou, Niki, Rosell, Rafael

Volltext

Science and biology drives the immune system to cure lung cancer patients: a revolution but not without challenges von Karachaliou, Niki, Rosell, Rafael

Volltext

Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins von Neel, Dana S, Allegakoen, David V, Olivas, Victor, Mayekar, Manasi K, Hemmati, Golzar, Chatterjee, Nilanjana, Blakely, Collin M, McCoach, Caroline E, Rotow, Julia K, Le, Anh, Karachaliou, Niki, Rosell, Rafael, Riess, Jonathan W, Nichols, Robert, Doebele, Robert C, Bivona, Trever G

Volltext

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial von Rosell, Rafael, Prof, Dafni, Urania, Prof, Felip, Enriqueta, MD, Curioni-Fontecedro, Alessandra, MD, Gautschi, Oliver, MD, Peters, Solange, MD, Massutí, Bartomeu, MD, Palmero, Ramon, MD, Aix, Santiago Ponce, MD, Carcereny, Enric, MD, Früh, Martin, MD, Pless, Miklos, MD, Popat, Sanjay, FRCP, Kotsakis, Athanasios, MD, Cuffe, Sinead, MD, Bidoli, Paolo, MD, Favaretto, Adolfo, MD, Froesch, Patrizia, MD, Reguart, Noemí, MD, Puente, Javier, MD, Coate, Linda, MD, Barlesi, Fabrice, Prof, Rauch, Daniel, MD, Thomas, Michael, Prof, Camps, Carlos, MD, Gómez-Codina, Jose, MD, Majem, Margarita, MD, Porta, Rut, MD, Shah, Riyaz, FRCP, Hanrahan, Emer, MRCPI, Kammler, Roswitha, BA, Ruepp, Barbara, PharmD, Rabaglio, Manuela, MD, Kassapian, Marie, MSc, Karachaliou, Niki, MD, Tam, Rachel, BSc, Shames, David S, PhD, Molina-Vila, Miguel A, PhD, Stahel, Rolf A, Dr

Volltext